Skip to main content

Market Overview

Tickers

Articles

Keywords

Search by keyword...
googlecse

JP Morgan Raises PT On Alkermes To $21
Joe Young  
 
May 19, 2011 7:33am   Comments
Share:

JP Morgan has raised the price target on Alkermes (NASDAQ: ALKS) from $16 to $21 and maintains its Overweight rating.

© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

 

Related Articles (ALKS)

Earnings Scheduled For July 29, 2025
Alkermes Oral Drug Helps Patients Stay Awake In Mid-Stage Sleep Disorder Study
Expert Outlook: Alkermes Through The Eyes Of 6 Analysts
Nvidia To Rally More Than 38%? Here Are 10 Top Analyst Forecasts For Tuesday
This Cooper Companies Analyst Turns Bullish; Here Are Top 3 Upgrades For Tuesday
Alkermes Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)
View Comments and Join the Discussion!

Posted-In: alkermes JP MorganPrice Target Analyst Ratings

Latest Ratings

StockFirmActionPT
SEDGB of A SecuritiesMaintains411.0
PTLOPiper SandlerMaintains28.0
AOUTLake StreetMaintains26.0
RAPTPiper SandlerMaintains52.0
OCXLake StreetMaintains6.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com